Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Bertin Bioreagent
IFN-γ 1 (pig) ELISA Kit
As low as
686
CHF
CHF 686.00
In stock
Only %1 left
BRT-A05413-KI0196 wellsCHF 686.00
NEW

Product Details | |
---|---|
Synonyms | Interferon-gamma; Type II interferon; IFNG |
Product Type | Kit |
Properties | |
Application Set | Quantitative ELISA |
Specificity | refer to technical booklet |
Sensitivity | ≤ 0,08 ng/mL |
Range | 0,08-10,00 ng/mL |
Sample Type | Determined by Customer |
Assay Type | Sandwich |
Other Product Data |
Click here for Original Manufacturer Product Datasheet |
Declaration | Manufactured by Bertin Bioreagent |
Shipping and Handling | |
Shipping | BLUE ICE |
Long Term Storage | +4°C |
Use/Stability | 6 months after the day of manufacturing. See expiry date on ELISA Kit box. |
Documents | |
Product Specification Sheet | |
Datasheet |
![]() |
Description
Also known as type II interferons, IFN-γ is a glycoprotein of 146 amino acids. IFN-γ is a cytokine critical for the innate and adaptive immunity. It is produced predominantly by natural killer (NK) and natural killer T (NKT) cells as part of the innate immune response and by T helper cells and cytotoxic T lymphocyte (CTL) as part of the adaptive immunity. IFN-γ has antiviral, immunoregulatory, and anti-tumor properties. IFN-γ promotes the NK cell activity, increases the antigen presentation by action on the lysosome activity of macrophages, promotes Th1 differentiation, and suppresses Th2 differentiation which would cause a humoral (antibody) response, modulates the production of IgG2a and IgG3 from activated plasma B cells, increases expression of class I MHC molecules as well as class II MHC on antigen-presenting cells, promotes adhesion and binding required for leukocyte migration. IFN-γ interacts with other cytokines, either in a synergistic (e.g., TNF) or antagonistic (e.g., IL-4) fashion. Enzyme ImmunoAssay (EIA) is a technique to detect and quantify antigens (proteins, hormones�) or antibodies in samples. It relies on the ability of an antibody to bind a specific antigen. Either the antibody or the antigen is labelled with an enzyme whose substrate is a chromogen or a fluorogen converted in a measurable product (color or fluorescence). Enzyme-linked Immunosorbent Assay (ELISA) is a type of EIA using a solid phase (ex: microtiter plate) coated with an antigen immobilizing the molecule to detect. Over the time, scientists have extended the term ELISA to EIAs using an antibody coating the solid phase. That explains why our EIA kits using coated antibodies are also called ELISA kits.